Atyr Pharma

ATYRNasdaq United States Health Care Biotechnology: Biological Products (No Diagnostic Substances)

Market cap

$50.143 M

$0.51 +1.87%

Close of 7 Aug 2026

Revenue

$190.0K

#3593 by revenue

Earnings

-$74.1M

Loss-making

Shares outstanding

98,087,425

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Biological Products (No Diagnostic Substances) — ranked by market cap

All 160 →

#127OKYO PharmaOKYO$50.4M
#128Instil BioTIL$50.3M
#129Atyr PharmaATYR$50.1M
#130Black Hawk AcquisitionBKHA$48.9M
#131ExozymesEXOZ$47.0M

Where these numbers come from

Share counts and financials for Atyr Pharma are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.